Temat: "CARDIOMYOPATHIES" - OpacWWW

Starter badań:

Cardiomyopathy.

Individuals whose family members have cardiomyopathy are at risk for the disease. Other risk factors include alcohol abuse or alcoholism, obesity, diabetes, hypertension, heart attack, coronary artery disease, and the use of certain drugs. Certain conditions can also damage the heart and cause cardiomyopathy, including hemochromatosis, sarcoidosis, and amyloidosis.

Salem Press Encyclopedia of Health, 2019. 2p.

Skocz do pozycji: 1 1.

Tytuł :: Sex-Related Differences in Genetic Cardiomyopathies.
Autorzy :: Argirò A; Cardiomyopathy Unit Careggi University Hospital Florence Italy.; Department of Experimental and Clinical Medicine University of Florence Italy.; Division of General Cardiology Careggi University Hospital Florence Italy.
Ho C; Cardiovascular Division Brigham and Women's HospitalHarvard Medical School Boston MA.
Day SM; Division of Cardiovascular Medicine Perelman School of MedicineUniversity of Pennsylvania Philadelphia PA.
van der Velden J; Department of Physiology Amsterdam Cardiovascular Sciences Amsterdam University Medical Center Vrije Universiteit Amsterdam Netherlands.
Cerbai E; Department of Neurosciences, Psychology, Drug Research and Child Health University of Florence Italy.
Saberi S; Division of Cardiovascular Medicine Department of Internal Medicine University of MichiganMichigan Medicine Ann Arbor MI.
Tardiff JC; Department of Biomedical Engineering The University of Arizona Tucson AZ.
Lakdawala NK; Cardiovascular Division Brigham and Women's HospitalHarvard Medical School Boston MA.
Olivotto I; Cardiomyopathy Unit Careggi University Hospital Florence Italy.; Department of Experimental and Clinical Medicine University of Florence Italy.; Division of General Cardiology Careggi University Hospital Florence Italy.; Pokaż więcej
Źródło :: Journal of the American Heart Association [J Am Heart Assoc] 2022 May 03; Vol. 11 (9), pp. e024947. Date of Electronic Publication: 2022 Apr 26.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Cardiomyopathies*/epidemiology
Cardiomyopathies*/genetics
Cardiomyopathy, Restrictive*/genetics
Female ; Humans ; Male ; Myocardium ; Phenotype ; Sex Characteristics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Trends and Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic and Nonischemic Cardiomyopathy.
Autorzy :: Sciria CT; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Kogan EV; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Ip JE; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Thomas G; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Liu CF; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Markowitz SM; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Lerman BB; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Kim LK; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Cheung JW; Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital and the Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.; Pokaż więcej
Źródło :: Circulation. Arrhythmia and electrophysiology [Circ Arrhythm Electrophysiol] 2022 Apr; Vol. 15 (4), pp. e010742. Date of Electronic Publication: 2022 Mar 28.
Typ publikacji :: Letter
MeSH Terms :: Cardiomyopathies*/complications
Cardiomyopathies*/surgery
Catheter Ablation*
Tachycardia, Ventricular*/diagnosis
Tachycardia, Ventricular*/surgery
Arrhythmias, Cardiac/surgery ; Humans ; Treatment Outcome
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.
Autorzy :: Chew DS; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.; Department of Cardiac Sciences, Libin Cardiovascular Institute (D.S.C.), University of Calgary, Alberta, Canada.; O'Brien Institute for Public Health (D.S.C.), University of Calgary, Alberta, Canada.
Cowper PA; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.
Al-Khalidi H; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.; Department of Biostatistics and Bioinformatics (H.A., K.J.A.), Duke University, Durham, NC.
Anstrom KJ; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.; Department of Biostatistics and Bioinformatics (H.A., K.J.A.), Duke University, Durham, NC.
Daniels MR; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.
Davidson-Ray L; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.
Li Y; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.
Michler RE; Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Bronx, NY (R.E.M.).
Panza JA; Department of Cardiology, Westchester Medical Center, Westchester Medical Center Health Network, Valhalla, NY (J.A.P.).
Piña IL; Department of Medicine, Wayne State University, Detroit, MI (I.L.P.).
Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Canada (J.L.R.).
Velazquez EJ; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT (E.J.V.).
Mark DB; Duke Clinical Research Institute (D.S.C., P.A.C., H.A., K.J.A., M.R.D., L.D.-R., Y.L., D.B.M.), Duke University, Durham, NC.; Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC (D.B.M.).; Pokaż więcej
Corporate Authors :: STICH Investigators
Źródło :: Circulation [Circulation] 2022 Mar 15; Vol. 145 (11), pp. 819-828. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji :: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: Cardiomyopathies*/etiology
Cardiomyopathies*/surgery
Myocardial Ischemia*/surgery
Coronary Artery Bypass/adverse effects ; Cost-Benefit Analysis ; Humans ; Stroke Volume ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Myocardium-specific Isca1 knockout causes iron metabolism disorder and myocardial oncosis in rat.
Autorzy :: Ling Y; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Yang X; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Zhang X; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Guan F; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Qi X; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Dong W; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Liu M; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Ma J; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Jiang X; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Gao K; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Li J; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Chen W; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Gao S; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Gao X; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Pan S; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Wang J; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
Ma Y; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China.
Lu D; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China. Electronic address: .
Zhang L; Key Laboratory of Human Disease Comparative Medicine, National Health Commission of China (NHC), Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China; National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Peking Union Medicine College, Beijing, China. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2022 May 15; Vol. 297, pp. 120485. Date of Electronic Publication: 2022 Mar 15.
Typ publikacji :: Journal Article
MeSH Terms :: Cardiomyopathies*/genetics
Cardiomyopathies*/metabolism
Iron Metabolism Disorders*/metabolism
Animals ; Male ; Mitochondria/genetics ; Mitochondria/metabolism ; Myocardium/metabolism ; Myocytes, Cardiac/metabolism ; Rats
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Predictors of Hospital Admissions for Ventricular Arrhythmia or Cardiac Arrest in Patients With Cardiomyopathy.
Autorzy :: Zacharia EM; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Istvanic F; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Mulukutla S; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Thoma F; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Aronis KN; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Bhonsale A; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Kancharla K; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Voigt A; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Shalaby A; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Estes NAM 3rd; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Jain SK; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Saba S; Cardiology Division of the Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address: .; Pokaż więcej
Źródło :: The American journal of cardiology [Am J Cardiol] 2022 May 15; Vol. 171, pp. 127-131. Date of Electronic Publication: 2022 Mar 12.
Typ publikacji :: Journal Article
MeSH Terms :: Cardiomyopathies*/complications
Cardiomyopathies*/epidemiology
Cardiomyopathies*/therapy
Defibrillators, Implantable*
Heart Arrest*
Arrhythmias, Cardiac/epidemiology ; Arrhythmias, Cardiac/therapy ; Death, Sudden, Cardiac ; Hospitalization ; Hospitals ; Humans ; Risk Factors ; Stroke Volume ; Ventricular Function, Left
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Diagnostic value of combined detection of IL-1β, IL-6, and TNF-α for sepsis-induced cardiomyopathy.
Autorzy :: Deng P; Department of Cardiology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province, China.
Tang N; Department of Cardiology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province, China.
Li L; Department of Cardiology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province, China.
Zou G; Department of Cardiology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province, China.
Xu Y; Department of Cardiology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province, China.
Liu Z; Department of Cardiology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi Province, China. Electronic address: .; Pokaż więcej
Źródło :: Medicina clinica [Med Clin (Barc)] 2022 May 13; Vol. 158 (9), pp. 413-417. Date of Electronic Publication: 2021 Jun 17.
Typ publikacji :: Journal Article
MeSH Terms :: Cardiomyopathies*/diagnosis
Cardiomyopathies*/etiology
Sepsis*/complications
Sepsis*/diagnosis
Cytokines ; Humans ; Interleukin-1beta ; Interleukin-6 ; Tumor Necrosis Factor-alpha
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: CircRNA CDR1as promotes cardiomyocyte apoptosis through activating hippo signaling pathway in diabetic cardiomyopathy.
Autorzy :: Shao Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Li M; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Yu Q; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Gong M; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Wang Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Yang X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Liu L; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Liu D; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Tan Z; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Zhang Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Qu Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Li H; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Wang Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Jiao L; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China.
Zhang Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, 150081, PR China. Electronic address: .; Pokaż więcej
Źródło :: European journal of pharmacology [Eur J Pharmacol] 2022 May 05; Vol. 922, pp. 174915. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji :: Journal Article
MeSH Terms :: Diabetes Mellitus*/metabolism
Diabetic Cardiomyopathies*/genetics
Diabetic Cardiomyopathies*/metabolism
Animals ; Apoptosis/genetics ; Hippo Signaling Pathway ; Humans ; Mammals/genetics ; Mice ; Myocytes, Cardiac/metabolism ; RNA, Circular/genetics ; Signal Transduction ; Transcription Factors/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Acacetin attenuates diabetes-induced cardiomyopathy by inhibiting oxidative stress and energy metabolism via PPAR-α/AMPK pathway.
Autorzy :: Song F; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China.
Mao YJ; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China.
Hu Y; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China.
Zhao SS; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China.
Wang R; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China.
Wu WY; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China. Electronic address: .
Li GR; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China; Nanjing Amazigh Pharma Limited, Nanjing, Jiangsu, 210032, China.
Wang Y; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China.
Li G; Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, Fujian province, China. Electronic address: .; Pokaż więcej
Źródło :: European journal of pharmacology [Eur J Pharmacol] 2022 May 05; Vol. 922, pp. 174916. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji :: Journal Article
MeSH Terms :: Diabetes Mellitus*/metabolism
Diabetic Cardiomyopathies*/drug therapy
Diabetic Cardiomyopathies*/metabolism
AMP-Activated Protein Kinases/metabolism ; Animals ; Apoptosis ; Energy Metabolism ; Flavones ; Glucose/metabolism ; Humans ; Interleukin-6/metabolism ; Myocytes, Cardiac/metabolism ; Oxidative Stress ; Peroxisome Proliferator-Activated Receptors ; Rats ; bcl-2-Associated X Protein/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study.
Autorzy :: Merlo M; Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Via Valdoni 1, 34149 Trieste, Italy.
Porcari A; Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Via Valdoni 1, 34149 Trieste, Italy.
Pagura L; Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Via Valdoni 1, 34149 Trieste, Italy.
Cameli M; Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Viale Mario Bracci 16, 53100, Siena, Italy.
Vergaro G; Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio and Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Via Giuseppe Moruzzi 1, 56124, Pisa, Italy.
Musumeci B; Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University, Via di Grottarossa 1035-39, 00189, Rome, Italy.
Biagini E; Department of Experimental, Diagnostic and Specialty Medicine, Cardiology Unit, IRCCS, University Sant'Orsola Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Canepa M; Department of Internal Medicine, Cardiovascular Unit, University of Genova, Viale Benedetto XV 10, 16132, Genova, Italy.; Ospedale Policlinico San Martino IRCCS, Largo Rosanna Benzi 10, 16132, Genova, Italy.
Crotti L; Department of Cardiovascular, Neural and Metabolic Sciences, Cardiomyopathy Unit, Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.; Department of Medicine and Surgery, University Milano, Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy.
Imazio M; Division of Cardiology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Turin, Corso Bramante 88, 10126, Turin, Italy.
Forleo C; Department of Emergency and Organ Transplantation, Cardiology Unit, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124, Bari, Italy.
Cappelli F; Cardiomyopathy Unit, Careggi University Hospital, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Favale S; Department of Emergency and Organ Transplantation, Cardiology Unit, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124, Bari, Italy.
Di Bella G; Department of Cardiology, University of Messina, Via Consolare Valeria 1, 98125, Messina, Italy.
Dore F; Department of Nuclear Medicine, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Strada di Fiume 447, 34129, Trieste, Italy.
Lombardi CM; Cardiology, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
Pavasini R; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Via Aldo Moro 8, 44124, Ferrara, Italy.
Rella V; Department of Cardiovascular, Neural and Metabolic Sciences, Cardiomyopathy Unit, Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.
Palmiero G; Department of Translational Medical Sciences, Inherited and Rare Heart Disease, Vanvitelli Cardiology, University of Campania Luigi Vanvitelli, Piazza Luigi Miraglia 2, 80138, Napoli, Italy.
Caiazza M; Department of Translational Medical Sciences, Inherited and Rare Heart Disease, Vanvitelli Cardiology, University of Campania Luigi Vanvitelli, Piazza Luigi Miraglia 2, 80138, Napoli, Italy.
Albanese M; Department of Emergency and Organ Transplantation, Cardiology Unit, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124, Bari, Italy.
Guaricci AI; Department of Emergency and Organ Transplantation, Cardiology Unit, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124, Bari, Italy.
Branzi G; Department of Cardiovascular, Neural and Metabolic Sciences, Cardiomyopathy Unit, Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.
Caponetti AG; Department of Experimental, Diagnostic and Specialty Medicine, Cardiology Unit, IRCCS, University Sant'Orsola Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
Saturi G; Department of Experimental, Diagnostic and Specialty Medicine, Cardiology Unit, IRCCS, University Sant'Orsola Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.
La Malfa G; Department of Internal Medicine, Cardiovascular Unit, University of Genova, Viale Benedetto XV 10, 16132, Genova, Italy.
Merlo AC; Department of Internal Medicine, Cardiovascular Unit, University of Genova, Viale Benedetto XV 10, 16132, Genova, Italy.
Andreis A; Division of Cardiology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Turin, Corso Bramante 88, 10126, Turin, Italy.
Bruno F; Division of Cardiology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Turin, Corso Bramante 88, 10126, Turin, Italy.
Longo F; Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Via Valdoni 1, 34149 Trieste, Italy.
Sfriso E; Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Via Valdoni 1, 34149 Trieste, Italy.
Di Ienno L; Cardiology Unit, Azienda Ospedaliero Universitaria di Ferrara, Cona, Via Aldo Moro 8, 44124, Ferrara, Italy.
De Carli G; Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Viale Mario Bracci 16, 53100, Siena, Italy.
Giacomin E; Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Viale Mario Bracci 16, 53100, Siena, Italy.
Spini V; Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio and Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Via Giuseppe Moruzzi 1, 56124, Pisa, Italy.
Milidoni A; Cardiology, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
Limongelli G; Department of Translational Medical Sciences, Inherited and Rare Heart Disease, Vanvitelli Cardiology, University of Campania Luigi Vanvitelli, Piazza Luigi Miraglia 2, 80138, Napoli, Italy.
Autore C; Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University, Via di Grottarossa 1035-39, 00189, Rome, Italy.
Olivotto I; Cardiomyopathy Unit, Careggi University Hospital, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Badano L; Department of Cardiovascular, Neural and Metabolic Sciences, Cardiomyopathy Unit, Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.; Department of Medicine and Surgery, University Milano, Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy.
Parati G; Department of Cardiovascular, Neural and Metabolic Sciences, Cardiomyopathy Unit, Istituto Auxologico Italiano, Piazzale Brescia, 20, 20149, Milan, Italy.; Department of Medicine and Surgery, University Milano, Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy.
Perlini S; Emergency Department and Amyloid Research and Treatment Center, IRCCS Policlinico San Matteo Foundation, Viale Camillo Golgi 19, 27100, Pavia, Italy.; Department of Internal Medicine, University of Pavia, Via Aselli 43/45, 27100, Pavia, Italy.
Metra M; Cardiology, Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
Emdin M; Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio and Istituto di Scienze della Vita, Scuola Superiore Sant'Anna, Via Giuseppe Moruzzi 1, 56124, Pisa, Italy.
Rapezzi C; Cardiovascular Center, University of Ferrara, Via Savonarola 9, 44121, Ferrara, Italy.; Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1, 48033, Cotignola, Italy.
Sinagra G; Cardiovascular Department, Center for Diagnosis and Treatment of Cardiomyopathies, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste, Via Valdoni 1, 34149 Trieste, Italy.; Pokaż więcej
Źródło :: European journal of preventive cardiology [Eur J Prev Cardiol] 2022 May 05; Vol. 29 (5), pp. e173-e177.
Typ publikacji :: Journal Article
MeSH Terms :: Amyloidosis*/diagnostic imaging
Amyloidosis*/epidemiology
Cardiomyopathies*/diagnostic imaging
Cardiomyopathies*/epidemiology
Emblems and Insignia*
Echocardiography ; Humans ; Prevalence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Response by Li and Chang Regarding Article, "Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy In Vivo".
Autorzy :: Li J; Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou Zhejiang, China. Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.
Chang X; Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou Zhejiang, China. Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.; Pokaż więcej
Źródło :: Circulation [Circulation] 2022 May 03; Vol. 145 (18), pp. e874-e875. Date of Electronic Publication: 2022 May 02.
Typ publikacji :: Letter
MeSH Terms :: Cardiomyopathies*/genetics
Cardiomyopathies*/therapy
Clustered Regularly Interspaced Short Palindromic Repeats*
Cytidine Deaminase/genetics ; Dystrophin/genetics ; Exons/genetics ; Humans
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Letter by Duan et al Regarding Article, "Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy In Vivo".
Autorzy :: Duan D; Department of Molecular Microbiology and Immunology and Department of Neurology, School of Medicine; Department of Biomedical Sciences, College of Veterinary Medicine; and Department of Biomedical, Biological & Chemical Engineering, College of Engineering, University of Missouri, Columbia (D.D.).
Flanigan KM; Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH (K.M.F.).; Department of Pediatrics, The Ohio State University College of Medicine, Columbus (K.M.F.).
Aartsma-Rus A; Department of Human Genetics, Leiden University Medical Center, The Netherlands (A.A.-R.).; Pokaż więcej
Źródło :: Circulation [Circulation] 2022 May 03; Vol. 145 (18), pp. e872-e873. Date of Electronic Publication: 2022 May 02.
Typ publikacji :: Letter
MeSH Terms :: Cardiomyopathies*/genetics
Cardiomyopathies*/therapy
Clustered Regularly Interspaced Short Palindromic Repeats*
Cytidine Deaminase/genetics ; Dystrophin/genetics ; Exons/genetics ; Humans
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Radial strain imaging-guided lead placement for improving response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy: the Raise CRT trial.
Autorzy :: Glikson M; Integrated Heart Centre, Shaare Zedek Medical Centre, Hebrew University, Jerusalem, Israel.; Arrhythmia center, Sheba Medical Centre, Tel Aviv University, Tel Hashomer, Israel.
Beinart R; Arrhythmia center, Sheba Medical Centre, Tel Aviv University, Tel Hashomer, Israel.
Golovchiner G; Department of cardiology, Rabin MC, Tel Aviv University, Petah Tikva, Israel.
Sheshet AB; Department of cardiology, Rabin MC, Tel Aviv University, Petah Tikva, Israel.
Swissa M; Department of cardiology, Kaplan MC, Hebrew University, Rehovot, Israel.
Bolous M; Department of cardiology, Rambam MC, Technion Institute, Haifa, Israel.
Rosso R; Department of cardiology, Tel Aviv Souraski MC, Tel Aviv University, Tel Aviv, Israel.
Medina A; Integrated Heart Centre, Shaare Zedek Medical Centre, Hebrew University, Jerusalem, Israel.
Haim M; Department of cardiology, Soroka MC, Ben Gurion University, Beer Sheba, Israel.
Friedman P; Department of cardiovascular medicine, Mayo Clinic, Rochester, MN, USA.
Khalamaizer V; Department of cardiology, Barzilai MC, Ben Gurion University, Ashkelon, Israel.
Benzvi S; Israeli Centre for Cardiovascular Research, Tel Hashomer, Israel.
Ito S; Department of cardiovascular medicine, Mayo Clinic, Rochester, MN, USA.
Goldenberg I; Israeli Centre for Cardiovascular Research, Tel Hashomer, Israel.; University of Rochester, Rochester, NY, USA.
Klempfner R; Israeli Centre for Cardiovascular Research, Tel Hashomer, Israel.
Vaturi O; Arrhythmia center, Sheba Medical Centre, Tel Aviv University, Tel Hashomer, Israel.
Oh JK; Department of cardiovascular medicine, Mayo Clinic, Rochester, MN, USA.; Pokaż więcej
Źródło :: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology [Europace] 2022 May 03; Vol. 24 (5), pp. 835-844.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Cardiac Resynchronization Therapy*/adverse effects
Cardiac Resynchronization Therapy*/methods
Cardiomyopathies*/diagnostic imaging
Cardiomyopathies*/therapy
Heart Failure*/diagnostic imaging
Heart Failure*/therapy
Myocardial Ischemia*/complications
Myocardial Ischemia*/diagnostic imaging
Myocardial Ischemia*/therapy
Cardiac Resynchronization Therapy Devices ; Heart Ventricles ; Humans ; Prospective Studies ; Quality of Life ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Intra-atrial dissociation during catheter ablation of right septal atrial flutter in lamin cardiomyopathy.
Autorzy :: Nam MCY; Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Sparks PB; Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Pokaż więcej
Źródło :: Internal medicine journal [Intern Med J] 2022 May; Vol. 52 (5), pp. 889-890.
Typ publikacji :: Letter
MeSH Terms :: Atrial Flutter*/etiology
Atrial Flutter*/surgery
Cardiomyopathies*/complications
Cardiomyopathies*/diagnostic imaging
Catheter Ablation*/adverse effects
Arrhythmias, Cardiac ; Heart Atria/surgery ; Humans
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress.
Autorzy :: Chen D; Department of General Geriatrics Division, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Ruan X; Department of General Geriatrics Division, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Liu Y; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, Guangxi, China.
He Y; Department of General Geriatrics Division, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.; Pokaż więcej
Źródło :: Bioengineered [Bioengineered] 2022 May; Vol. 13 (5), pp. 11417-11429.
Typ publikacji :: Journal Article
MeSH Terms :: Diabetes Mellitus*
Diabetic Cardiomyopathies*/genetics
Diabetic Cardiomyopathies*/metabolism
Diabetic Cardiomyopathies*/pathology
Antioxidants ; Apoptosis/genetics ; Cell Survival/genetics ; Glucose/toxicity ; Humans ; Hydroxymethylglutaryl-CoA Synthase/metabolism ; Inflammation/genetics ; Inflammation/pathology ; Oxidative Stress ; Superoxide Dismutase/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Changing concepts in heart muscle disease: the evolving understanding of hypertrophic cardiomyopathy.
Autorzy :: Moody WE; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Department of Cardiology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Elliott PM; Institute of Cardiovascular Science, University College London, London, UK .; Pokaż więcej
Źródło :: Heart (British Cardiac Society) [Heart] 2022 May; Vol. 108 (10), pp. 768-773.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Cardiomyopathies*
Cardiomyopathy, Hypertrophic*/diagnosis
Cardiomyopathy, Hypertrophic*/genetics
Cardiomyopathy, Hypertrophic*/therapy
Artificial Intelligence ; Humans ; Myocardium ; Quality of Life
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Serum cardiac troponin I is a candidate biomarker for cardiomyopathy in Duchenne and Becker muscular dystrophies.
Autorzy :: Yamaguchi H; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Awano H; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Yamamoto T; Nagahama Institute of Bio-Science and Technology, Nagahama, Japan.
Nambu Y; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.; Director, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.; Pokaż więcej
Źródło :: Muscle & nerve [Muscle Nerve] 2022 May; Vol. 65 (5), pp. 521-530. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Cardiomyopathies*/etiology
Cardiomyopathies*/genetics
Muscular Dystrophy, Duchenne*/complications
Muscular Dystrophy, Duchenne*/diagnosis
Muscular Dystrophy, Duchenne*/genetics
Actinin/genetics ; Adolescent ; Biomarkers ; Humans ; Retrospective Studies ; Stroke Volume ; Troponin I ; Ventricular Function, Left
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Exploring the Pattern of Metabolic Alterations Causing Energy Imbalance via PPARα Dysregulation in Cardiac Muscle During Doxorubicin Treatment.
Autorzy :: Renu K; Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu, 632014, India.
Vinayagam S; Department of Biotechnology, Periyar University, PG Extension Centre, Dharmapuri, Tamil Nadu, 636701, India.
Madhyastha H; Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki, 889 1692, Japan.
Madhyastha R; Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki, 889 1692, Japan.
Maruyama M; Department of Applied Physiology, Faculty of Medicine, University of Miyazaki, Miyazaki, 889 1692, Japan.
Suman S; Department of Oncology, Lombardi Comprehensive Cancer Center (LCCC), Georgetown University Medical Center (GUMC), E504, NRB, 3970 Reservoir Rd. NW, Washington, DC, USA.
Arunachalam S; Department of Biotechnology, Kalasaligam Academy of Research and Education, Krishnankoil, 626126, Tamil Nadu, India.
Vellingiri B; Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, Tamil Nadu, 641 046, India.
Valsala Gopalakrishnan A; Department of Biomedical Sciences, School of Biosciences and Technology, VIT, Vellore, Tamil Nadu, 632014, India. .; Pokaż więcej
Źródło :: Cardiovascular toxicology [Cardiovasc Toxicol] 2022 May; Vol. 22 (5), pp. 436-461. Date of Electronic Publication: 2022 Feb 14.
Typ publikacji :: Journal Article
MeSH Terms :: Cardiomyopathies*/chemically induced
Cardiomyopathies*/metabolism
PPAR alpha*/metabolism
Animals ; Body Weight ; Cardiotoxicity/metabolism ; Doxorubicin/adverse effects ; Fatty Acids/metabolism ; Heart/drug effects ; Lipid Metabolism ; Male ; Myocardium/metabolism ; Rats
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges.
Autorzy :: Thoi F; School of Medicine, University of Adelaide, Adelaide, SA, Australia.
Scherer DJ; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia; Heart Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Kaye DM; Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, SA, Australia; Department of Clinical Research, The Baker Heart and Diabetes Institute; Department of Cardiology, The Alfred Hospital; Department of Medicine, Monash University, Melbourne, Vic, Australia.
Sanders P; School of Medicine, University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia; Heart Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, SA, Australia. Electronic address: https://twitter.com/PrashSanders.
Stokes MB; School of Medicine, University of Adelaide, Adelaide, SA, Australia; Department of Cardiology, Central Adelaide Local Health Network, Adelaide, SA, Australia; Heart Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia; Centre for Heart Rhythm Disorders, University of Adelaide, Adelaide, SA, Australia. Electronic address: .; Pokaż więcej
Źródło :: Heart, lung & circulation [Heart Lung Circ] 2022 May; Vol. 31 (5), pp. 616-622. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Amphetamine-Related Disorders*/complications
Cardiomyopathies*/chemically induced
Cardiomyopathies*/therapy
Heart Failure*/chemically induced
Heart Failure*/therapy
Methamphetamine*/adverse effects
Cytidine Monophosphate ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Clinical characteristics of primary carnitine deficiency: A structured review using a case-by-case approach.
Autorzy :: Crefcoeur LL; Department of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Laboratory Genetic Metabolic Diseases, Amsterdam UMC location Academic Medical Center, University of Amsterdam, Amsterdam Gastroenterology and Metabolism, Amsterdam, The Netherlands.
Visser G; Department of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.; Laboratory Genetic Metabolic Diseases, Amsterdam UMC location Academic Medical Center, University of Amsterdam, Amsterdam Gastroenterology and Metabolism, Amsterdam, The Netherlands.
Ferdinandusse S; Laboratory Genetic Metabolic Diseases, Amsterdam UMC location Academic Medical Center, University of Amsterdam, Amsterdam Gastroenterology and Metabolism, Amsterdam, The Netherlands.
Wijburg FA; Emma's Children's Hospital, Amsterdam UMC location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Langeveld M; Department of Endocrinology and Metabolism, Amsterdam UMC location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Sjouke B; Department of Endocrinology and Metabolism, Amsterdam UMC location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.; Pokaż więcej
Źródło :: Journal of inherited metabolic disease [J Inherit Metab Dis] 2022 May; Vol. 45 (3), pp. 386-405. Date of Electronic Publication: 2022 Feb 03.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Cardiomyopathies*/complications
Cardiomyopathies*/diagnosis
Cardiomyopathies*/genetics
Hyperammonemia*/complications
Hyperammonemia*/diagnosis
Hyperammonemia*/genetics
Muscular Diseases*/complications
Muscular Diseases*/diagnosis
Muscular Diseases*/genetics
Carnitine/deficiency ; Carnitine/metabolism ; Child, Preschool ; Humans ; Infant, Newborn ; Neonatal Screening/methods ; Solute Carrier Family 22 Member 5/genetics
SCR Disease Name :: Systemic carnitine deficiency
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: A systematic review.
Autorzy :: Stalikas N; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of Cardiology, 424 General Military Training Hospital, Thessaloniki, Greece.
Doundoulakis I; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of Cardiology, 424 General Military Training Hospital, Thessaloniki, Greece.
Karagiannidis E; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kartas A; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Gavriilaki M; First Department of Neurology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Sofidis G; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Panteris E; Biomic_Auth, Bioanalysis and Omics Lab, Centre for Interdisciplinary Research of Aristotle University of Thessaloniki, Innovation Area of Thessaloniki, Greece.
Papazoglou AS; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Haidich AB; Department of Hygiene, Social-Preventive Medicine & Medical Statistics, Medical School, Aristotle University of Thessaloniki, Greece.
Sianos G; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Giannakoulas G; Department of Cardiology, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: .; Pokaż więcej
Źródło :: European journal of internal medicine [Eur J Intern Med] 2022 May; Vol. 99, pp. 38-44. Date of Electronic Publication: 2022 Jan 20.
Typ publikacji :: Journal Article; Systematic Review
MeSH Terms :: Cardiomyopathies*/complications
Cardiomyopathies*/diagnosis
Cardiomyopathies*/epidemiology
Embolic Stroke*
Intracranial Embolism*
Stroke*/epidemiology
Aged ; Biomarkers ; Humans ; Prevalence ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""CARDIOMYOPATHIES"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Starter badań:

Cardiomyopathy.